(IN BRIEF) Researchers from The Institute of Cancer Research and The University of Manchester have created the most comprehensive map of cancer-related genetic mutations to date, analysing data from nearly 11,000 patients in the 100,000 Genomes Project. The study identified … Read the full press release
Posted in Education, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged 100000 Genomes Project, bowel cancer, breast cancer, cancer genomics, David Wedge, DNA mutations, Genomics England, homologous recombination deficiency, HRD, Institute of Cancer Research London, Landmark Study Advances Precision Oncology with Comprehensive Mapping of Cancer-Causing Genetic Mutations, Major Cancer Genomics Study Uncovers New Mutation Signatures Expanding Potential for Precision Treatments, microbiome, mutational signatures, oncology research, ovarian cancer, PARP inhibitors, precision medicine, Richard Houlston, University of Manchester
(IN BRIEF) Researchers at the Technical University of Munich have developed a new drug candidate that significantly enhances the effectiveness of the antibiotic metronidazole against Helicobacter pylori, a bacterium linked to stomach cancer. By introducing targeted chemical modifications, the team … Read the full press release
Posted in Chemicals, Education, Germany, Healthcare, Industrial, Management, Pharma & Biotech, Science, Technology
Tagged antibiotic resistance, biotechnology, drug development, Helicobacter pylori, Marianne Pandler, Markus Gerhard, metronidazole, Michael Groll, Michaela Fiedler, microbiome, Nature Microbiology, Oxidative stress, Stephan A. Sieber, stomach cancer, Technical University of Munich, TUM, TUM Researchers Achieve Breakthrough in Antibiotic Enhancement with New Compound Showing Strong Activity Against Resistant Bacteria
(IN BRIEF) Researchers at the Institute of Cancer Research and St Mark’s Hospital are launching a major study analysing historic bowel cancer samples dating back more than 70 years to understand why diagnoses are rising in people under 50. By … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Science, Technology, United Kingdom
Tagged bowel cancer, bowel cancer research, cancer diagnosis, cancer genomics, Cancer Prevention, DNA sequencing, early-onset cancer, environmental exposure, exposome, Historic Tumour Archive Study Aims to Explain Rising Bowel Cancer Rates in Under-50s, Institute of Cancer Research, lifestyle factors, microbiome, St Mark’s Hospital, tumour samples, Young Adults
(IN BRIEF) The Luxembourg Institute of Health (LIH) has announced five lecture series beginning this autumn and continuing through 2026, covering themes from microbiome research and causal inference to proteomics, cancer immunotherapy, and epidemiology. Led by LIH principal investigators and … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, Marketing, News, Science, Technology
Tagged Allini Mafra Da Costa, Bassam Janji, biomedical lecture series, cancer research, causal inference, Claudine Backes, epidemiology, FNR, Gunnar Dittmar, Jason Settels, Johannes Meiser, LIH, LISER, LIST, Luxembourg Institute of Health, Mahesh Desai, MICRO-PATH DTU, microbiome, National Cancer Registry, proteomics, Sophie Pilleron, University of Luxembourg
(IN BRIEF) Health Canada has granted authorization for the probiotic strain Lactobacillus acidophilus DDS-1® to make health claims related to the gut-brain axis. The strain is now approved to help alleviate perceived stress, improve irritable bowel syndrome (IBS)-related quality of … Read the full press release
Posted in Denmark, Food & Beverage, Healthcare, Pharma & Biotech, Science
Tagged Brain, Chr. Hansen, DDS-1®, digestive issues, gut, gut-brain axis, Health Canada, IBS, irritable bowel syndrome, L. acidophilus, Linda Neckmar, mental well-being, microbiome, Natural Health Product, Niklas Larsson PhD, NPH license, probiotic strain, stress
(IN BRIEF) A recent study conducted by researchers from the Universities of Warwick and Justus Liebig has found that promoting the natural relationship between plants and bacteria can reduce the need for environmentally damaging fertilizers. By enhancing the symbiotic relationship … Read the full press release
(PRESS RELEASE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to accelerate … Read the full press release
Posted in Education, Healthcare, Investment, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biomedical sciences, brain activity, brain development, Cancer, Cardiff University, Congenital Anomalies, CRUK Beatson Institute, Degron Tagging, disease modelling, Dr Andrew Wood, Dr David Kent, Dr Michael Ashby, Dr Robert Pitceathly, Haem, Institute of Cancer Research, King’s College London, Mary Lyon Centre, microbiome, Mitochondria, mouse genetics, MRC, MRC Harwell, MRC Human Genetics Unit, MRC National Mouse Genetics Network, MURIDAE, neurodevelopmental, neuropsychiatric disease, Owen Sansom, Prof Anthony Isles, Prof Fiona Powrie, Prof Karen Blyth, Prof Karen Liu, Prof Louis Chesler, psychiatric disorders, UCL Queen Square Institute of Neurology, University of Bristol, University of Edinburgh, University of Glasgow, University of Oxford, University of York
Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release
Posted in Austria, Business, France, Healthcare, News, Pharma & Biotech
Tagged acne, acne vulgaris, acquisition, antigens, biotechnology, Cutibacterium acnes bacterium, microbiome, mRNA, ORI-001, Origimm Biotechnology GmbH, Sanofi, Sanya Selak, skin disease, skin immunology, skin microbiome, Thomas Triomphe, virulent skin microbiome
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?